These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7562324)

  • 1. Periodontal variables affecting nifedipine sequestration in gingival crevicular fluid.
    Ellis JS; Seymour RA; Thomason JM; Butler TJ; Idle JR
    J Periodontal Res; 1995 Jul; 30(4):272-6. PubMed ID: 7562324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of phenytoin in gingival crevicular fluid and plasma in relation to gingival overgrowth.
    McLaughlin WS; Ball DE; Seymour RA; Kamali F; White K
    J Clin Periodontol; 1995 Dec; 22(12):942-5. PubMed ID: 8613563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iatrogenic gingival overgrowth in cardiac transplantation.
    Thomason JM; Seymour RA; Ellis JS; Kelly PJ; Parry G; Dark J; Idle JR
    J Periodontol; 1995 Aug; 66(8):742-6. PubMed ID: 7473018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crevicular fluid interleukin-1beta, tumor necrosis factor-alpha, and interleukin-6 levels in renal transplant patients receiving cyclosporine A.
    Atilla G; Kütükçüler N
    J Periodontol; 1998 Jul; 69(7):784-90. PubMed ID: 9706856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study.
    Ellis JS; Seymour RA; Steele JG; Robertson P; Butler TJ; Thomason JM
    J Periodontol; 1999 Jan; 70(1):63-7. PubMed ID: 10052772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifedipine pharmacological variables as risk factors for gingival overgrowth in organ-transplant patients.
    Thomason JM; Ellis JS; Kelly PJ; Seymour RA
    Clin Oral Investig; 1997 Feb; 1(1):35-9. PubMed ID: 9552815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gingival sequestration of nifedipine in nifedipine-induced gingival overgrowth.
    Ellis JS; Seymour RA; Monkman SC; Idle JR
    Lancet; 1992 Jun; 339(8806):1382-3. PubMed ID: 1350808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of nifedipine in plasma and gingival crevicular fluid in relation to drug-induced gingival overgrowth.
    Ellis JS; Seymour RA; Monkman S; Idle JR
    J Periodontal Res; 1993 Sep; 28(5):373-8. PubMed ID: 8410602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine.
    Westbrook P; Bednarczyk EM; Carlson M; Sheehan H; Bissada NF
    J Periodontol; 1997 Jul; 68(7):645-50. PubMed ID: 9249636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases (MMP-8 and -9) and neutrophil elastase in gingival crevicular fluid of cyclosporin-treated patients.
    Atilla G; Sorsa T; Rönka H; Emingil G
    J Periodontol; 2001 Mar; 72(3):354-60. PubMed ID: 11327063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of p53, bcl-2, and interleukin-15 levels in gingival crevicular fluid of cyclosporin A-treated patients.
    Buduneli E; Genel F; Atilla G; Kütükçüler N
    J Periodontol; 2003 Apr; 74(4):506-11. PubMed ID: 12747456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of platelet-activating factor in gingival crevicular fluid and gingival tissue in specific periodontal diseases.
    Emingil G; Cinarcik S; Baylas H; Hüseyinov A
    J Periodontol; 2001 Aug; 72(8):1032-7. PubMed ID: 11525434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth.
    Thomason JM; Seymour RA; Rice N
    J Clin Periodontol; 1993 Jan; 20(1):37-40. PubMed ID: 8421114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical effects of nifedipine on periodontal status.
    Tavassoli S; Yamalik N; Caglayan F; Caglayan G; Eratalay K
    J Periodontol; 1998 Feb; 69(2):108-12. PubMed ID: 9526908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of leukotriene B4 and platelet activating factor in gingival crevicular fluid in renal transplant patients receiving cyclosporine A.
    Emingil G; Coker I; Atilla G; Hüseyinov A
    J Periodontol; 2000 Jan; 71(1):50-7. PubMed ID: 10695938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence and severity of nifedipine-induced gingival overgrowth.
    Barclay S; Thomason JM; Idle JR; Seymour RA
    J Clin Periodontol; 1992 May; 19(5):311-4. PubMed ID: 1517474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pharmacological variables as a risk factor for nifedipine-induced gingival overgrowth.
    Güncü GN; Cağlayan F; Dinçel A; Bozkurt A; Ozmen S; Karabulut E
    Aust Dent J; 2007 Dec; 52(4):295-9. PubMed ID: 18265685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and gingival crevicular fluid phenytoin concentrations as risk factors for gingival overgrowth.
    Güncü GN; Caglayan F; Dinçel A; Bozkurt A; Saygi S; Karabulut E
    J Periodontol; 2006 Dec; 77(12):2005-10. PubMed ID: 17209785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 Family of Cytokines in Crevicular Fluid of Renal Transplant Recipients With and Without Cyclosporine A-Induced Gingival Overgrowth.
    Gürkan A; Becerik S; Öztürk VÖ; Atmaca H; Atilla G; Emingil G
    J Periodontol; 2015 Sep; 86(9):1069-77. PubMed ID: 25927423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of leukotriene B4 in gingival crevicular fluid and gingival tissue in specific periodontal diseases.
    Emingil G; Cinarcik S; Baylas H; Coker I; Hüseyinov A
    J Periodontol; 2001 Aug; 72(8):1025-31. PubMed ID: 11525433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.